Enhancing Pharmacokinetics Workflows at Charles River
PreclinicalPhoenix™ Integral Data Repository Charles River, a global leader in drug development, sought to improve…
CertaraNovember 13, 2024
ATG-101 Is a Tetravalent PD-L1×4-1BB Bispecific Antibody That Stimulates Antitumor Immunity through PD-L1 Blockade and PD-L1–Directed 4-1BB Activation
Abstract Immune checkpoint inhibitors (ICI) have transformed cancer treatment. However, only a minority of patients…
CertaraNovember 13, 2024
PBPK Modeling to Support Bioequivalence & Generic Product Approvals
Physiologically-based pharmacokinetic modeling can be used to support bioequivalence (BE) assessment of complex and locally…
CertaraNovember 12, 2024
Shining a spotlight on Clinical Study Software at the 2024 Pinnacle 21 Enterprise User Group Meeting
Shining a spotlight on Clinical Study Software at the 2024 Pinnacle 21 Enterprise User Group Meeting
On October 30, 2024, we hosted our Pinnacle 21 Enterprise (P21E) User Group Meeting (UGM)…
CertaraNovember 12, 2024
4 Ways to Optimize Agency Partnerships Using a Platform-Oriented Approach
In the pharmaceutical and medical devices industries, the journey from product development to market introduction…
CertaraNovember 8, 2024
The Future of DIDB
Explore the future of the Drug Interaction Database (DIDB) in this on-demand webinar, featuring insights…
CertaraNovember 8, 2024
Why Clinical Pharmacology & Pharmacometrics Should Collaborate
A symbiosis between a modeler and a trialist is often required to develop a model-informed…
CertaraNovember 8, 2024
Comprehensive and Customized Toxicology Services
Comprehensive overview of toxicology services.
CertaraNovember 7, 2024
